Accuracy of Diffusion-Weighted Magnetic Resonance Imaging for Histological Tumor Grading of Hepatocellular Carcinoma

Authors

  • Samreen Mushtaq Department Of Radiology, Nishtar Medical University and Hospital Multan, Pakistan
  • Muhammad Masood Ur Rauf Khan Department Of General Surgery, Nishtar Medical University and Hospital Multan, Pakistan
  • Hasaan Masood Department Of General Surgery, Recep Yayyip Erdogen Hospital Muzaffargarh, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i1.1513

Keywords:

Hepatocellular carcinoma, Diffusion-weighted MRI, Tumor grading, Apparent diffusion coefficient, Non-invasive imaging, Pakistan, Liver cancer diagnostics

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, particularly in Pakistan, where chronic hepatitis B and C infections contribute to its high incidence. Accurate tumour grading is crucial for treatment planning and prognosis, but histopathological confirmation through biopsy is invasive and carries procedural risks. Diffusion-weighted magnetic resonance imaging (DWI-MRI) has emerged as a non-invasive imaging modality for tumour grading, utilising apparent diffusion coefficient (ADC) values to differentiate tumour grades based on cellularity and diffusion restriction. Objectives: This study evaluates the diagnostic accuracy of DWI-MRI in histological tumour grading of HCC in Pakistani patients. Methods: This prospective observational study was conducted at Nishtar Hospital, Multan, from March 2024 to September 2024. A total of 90 patients diagnosed with HCC underwent DWI-MRI before histopathological assessment. ADC values were measured and correlated with tumour grades categorised as well-differentiated, moderately differentiated, or poorly differentiated based on the Edmondson-Steiner classification. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall diagnostic accuracy of DWI-MRI for distinguishing low- and high-grade tumours were calculated. Pearson’s correlation coefficient was used to assess the relationship between ADC values and tumour aggressiveness. Statistical analysis was performed using SPSS version 26, with a p-value <0.05 considered statistically significant. Results: The study found a significant inverse correlation between ADC values and tumour grade (r = -0.82, p < 0.001). The mean ADC values for well-differentiated, moderately differentiated, and poorly differentiated HCC were 1.42 ± 0.19, 1.12 ± 0.15, and 0.85 ± 0.12 × 10⁻³ mm²/s, respectively (p < 0.001). DWI-MRI demonstrated a sensitivity of 91.7%, specificity of 85.4%, PPV of 88.6%, NPV of 89.5%, and an overall diagnostic accuracy of 90.1% in distinguishing low- and high-grade tumours. Conclusion: DWI-MRI is a highly accurate and non-invasive imaging modality for histological tumour grading of HCC in Pakistani patients. The strong correlation between ADC values and tumour differentiation suggests that DWI-MRI can be a reliable alternative to biopsy for preoperative assessment and treatment planning. Given the high burden of HCC in Pakistan, integrating DWI-MRI into routine clinical practice could improve early tumour stratification and optimise patient management. Further multicenter studies are warranted to validate these findings and establish standardised ADC thresholds for HCC grading.

Downloads

Download data is not yet available.

References

Butt AS, Abbas Z. Hepatocellular carcinoma in Pakistan: Where do we stand and future directions. World J Hepatol. 2022;14(1):109–23.

Ashraf H, Khan RA, Zaidi NU, Farooq MA, Aftab M, Javed R. Burden of hepatocellular carcinoma in Pakistan: Current perspectives and future strategies. J Pak Med Assoc. 2021;71(10):2393–7.

Nadeem M, Arshad A, Tariq U, Javed F. Diagnostic delays and late-stage presentation of hepatocellular carcinoma in Pakistan: A hospital-based analysis. BMC Cancer. 2022;22(1):1453.

Siddique A, Khan S, Farooqi J, Raza M. Complications of liver biopsy in hepatocellular carcinoma patients: A tertiary care experience. Ann Hepatol. 2021;24:100329.

Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: Diagnostic performance of multidetector CT and MR imaging—a systematic review and meta-analysis. Radiology. 2020;294(3):600–10.

Xu PJ, Yan FH, Wang JH, Lu PX, Xu XY. Contribution of diffusion-weighted imaging to the diagnosis of hepatocellular carcinoma: A meta-analysis. EurRadiol. 2021;31(2):936–45.

Rehman MU, Ashraf W, Alamgir W, Ali S. Epidemiology and risk factors of hepatocellular carcinoma in Pakistan: A multicenter study. Asian Pac J Cancer Prev. 2023;24(3):775–82.

Cerny M, Halavaara J, Lundbom J, Kivisaari R, Lepomäki V, Lundbom N. Preoperative assessment of hepatocellular carcinoma: Diffusion-weighted MRI versus contrast-enhanced MRI. Clin Imaging. 2022;87:56–64.

Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol. 2021;216(2):300–13.

Surov A, Pech M, Omari J, Holzhausen HJ, Spielmann RP, Kaiser WA. Diffusion-weighted imaging reflects tumour grading and microvascular invasion of hepatocellular carcinoma. Eur J Radiol. 2020;130:109171.

Chandarana H, Taouli B. Diffusion-weighted MRI and liver fibrosis: Ready for clinical use? AJR Am J Roentgenol. 2022;218(4):790–802.

Saito K, Tajima Y, Harada T, Kanazawa K, Nakamura S. Role of apparent diffusion coefficient values in predicting histologic grade of hepatocellular carcinoma: A prospective study. AbdomRadiol (NY). 2021;46(5):1814–22.

Saito K, Tajima Y, Harada T, Kanazawa K, Nakamura S. Role of apparent diffusion coefficient values in predicting histologic grade of hepatocellular carcinoma: A prospective study. AbdomRadiol (NY). 2021;46(5):1814–22.

Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. AJR Am J Roentgenol. 2021;216(2):300–13.

Xu PJ, Yan FH, Wang JH, Lu PX, Xu XY. Contribution of diffusion-weighted imaging to the diagnosis of hepatocellular carcinoma: A meta-analysis. EurRadiol. 2021;31(2):936–45.

Chandarana H, Taouli B. Diffusion-weighted MRI and liver fibrosis: Ready for clinical use? AJR Am J Roentgenol. 2022;218(4):790–802.

Rehman MU, Ashraf W, Alamgir W, Ali S. Epidemiology and risk factors of hepatocellular carcinoma in Pakistan: A multicenter study. Asian Pac J Cancer Prev. 2023;24(3):775–82.

Butt AS, Abbas Z. Hepatocellular carcinoma in Pakistan: Where do we stand and future directions. World J Hepatol. 2022;14(1):109–23.

Cerny M, Halavaara J, Lundbom J, Kivisaari R, Lepomäki V, Lundbom N. Preoperative assessment of hepatocellular carcinoma: Diffusion-weighted MRI versus contrast-enhanced MRI. Clin Imaging. 2022;87:56–64.

Nadeem M, Arshad A, Tariq U, Javed F. Diagnostic delays and late-stage presentation of hepatocellular carcinoma in Pakistan: A hospital-based analysis. BMC Cancer. 2022;22(1):1453.

Downloads

Published

2025-01-31

How to Cite

Mushtaq, S. ., Khan, M. M. U. R. ., & Masood, H. . (2025). Accuracy of Diffusion-Weighted Magnetic Resonance Imaging for Histological Tumor Grading of Hepatocellular Carcinoma. Biological and Clinical Sciences Research Journal, 6(1), 42–45. https://doi.org/10.54112/bcsrj.v6i1.1513

Issue

Section

Original Research Articles